Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	80	142	144	189	701	765
Market Cap Growth	-39.12%	-1.09%	-23.96%	-73.04%	-8.39%	-65.84%
Enterprise Value	120.31	169.01	195.94	254.29	678.44	517.33
Last Close Price	8.30	14.88	16.62	28.00	112.00	166.60
PE Ratio	13.14	23.25	-	-1.58	-2.42	-11.57
PS Ratio	105.34	180.23	-	-	-	5.28
PB Ratio	1.87	3.22	10.43	-4.21	65.03	5.82
P/TBV Ratio	1.67	2.99	9.37	-3.99	56.13	5.81
P/FCF Ratio	96.08	164.39	-0.96	-1.51	-2.94	-265.96
P/OCF Ratio	74.41	127.31	-0.97	-1.61	-3.06	114.45
EV/Sales Ratio	152.49	214.21	-	-	-	3.57
EV/EBITDA Ratio	-	-1.88	-1.69	-1.35	-3.60	-8.84
EV/EBIT Ratio	-	-1.80	-1.62	-1.30	-3.48	-8.02
EV/FCF Ratio	139.09	195.39	-1.32	-2.03	-2.84	-179.75
Debt / Equity Ratio	1.64	1.64	6.02	-4.31	14.70	0.32
Debt / EBITDA Ratio	-0.92	-0.92	-0.79	-1.05	-0.86	-0.84
Debt / FCF Ratio	95.91	95.91	-0.61	-1.59	-0.68	-17.10
Net Debt / Equity Ratio	0.84	0.84	4.41	-1.58	-1.74	-1.84
Net Debt / EBITDA Ratio	-0.41	-0.41	-0.52	-0.37	0.10	4.13
Net Debt / FCF Ratio	43.01	43.01	-0.41	-0.56	0.08	83.91
Asset Turnover	0.01	0.01	0	0	0	0.42
Quick Ratio	2.40	2.40	0.80	1.30	2.12	3.53
Current Ratio	2.56	2.56	0.94	1.78	2.28	3.69
Return on Equity (ROE)	19.64%	19.64%	809.55%	1116.02%	-267.24%	-42.83%
Return on Assets (ROA)	-67.60%	-67.60%	-48.68%	-55.16%	-55.45%	-18.48%
Return on Invested Capital (ROIC)	-117.49%	-117.49%	-86.36%	-132.43%	-408.64%	-168.82%
Return on Capital Employed (ROCE)	-86.43%	-86.43%	-67.67%	-74.59%	-72.83%	-22.66%
Earnings Yield	6.85%	4.30%	0.00%	-63.46%	-41.25%	-8.64%
FCF Yield	1.04%	0.61%	-103.63%	-66.29%	-34.03%	-0.38%
Buyback Yield / Dilution	-9.77%	-9.77%	-26.11%	-11.21%	-14.82%	-0.28%

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q